5-Bromoquinazolin-6-ylthiourea

We are 5-Bromoquinazolin-6-ylthiourea CAS:842138-74-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5-Bromoquinazolin-6-ylthiourea
CAS.NO:842138-74-3
Synonyms:5-Bromoquinazolin-6-ylthiourea
N-(5-BroMo-6-quinoxalinyl)thiourea
(5-BroMo-6-quinoxalinyl)thiourea
N-(5-BROMOQUINOXALIN-6-YL)THIOUREA
5-Bromoquinaxolin-6-ylthiourea
Thiourea,N-(5-broMo-6-quinoxalinyl)
 
Physical and Chemical Properties:
Density 1.8±0.1 g/cm3
Boiling Point 435.4±55.0 °C at 760 mmHg
Melting Point 198-202ºC
Molecular Formula C9H7BrN4S
Molecular Weight 283.148
Flash Point 217.1±31.5 °C
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.841
 
Specification:
Appearance:Light yellow to brown powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Brimonidine(CAS:59803-98-4) and Brimonidine tartrate(CAS:70359-46-5).

5-Bromoquinazolin-6-ylthiourea


Related News: In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.5-bromo-3-nitro-2-piridinol CAS:15862-34-7 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.1214369-42-2 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.1-cloro-8-fluorooctano CAS:593-14-6 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.

Related Products
Product Name
5-(Hydroxymethyl)thiazole View Details
1-Bromo-2-methylbutane View Details
3-Amino-2-fluorobenzoic acid View Details
2-Fluoronicotinic acid manufacturer 1-(2,3-difluorophenyl)ethanone manufacturer N-[5-Bromomethyl-4-(4-fluorophenyl)-6-isopropylpyrimidine-2-yl]-N-methylmethane sulfonamide manufacturer Cytarabine manufacturer 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one manufacturer